Stay updated with breaking news from Eric Benner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study from Duke University medical experts suggested that a fatty molecule found in breast milk could prevent and reverse the motor disorder cerebral palsy in premature infants
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
by Chantal Allam, NCBiotech writer — May 13, 2021 . RESEARCH TRIANGLE PARK – Tellus Therapeutics is pushing ahead with developing its neonatal brain injury treatment after landing crucial seed funding this week. The Durham-based biotech company focused on neonatal health announced that it had secured an undisclosed sum from Boston-based Xontogeny to advance its lead TT-20 program. The program targets diffuse white matter injury (DWMI) in preterm infants less than 32 weeks gestational age. Tellus “We are excited to team up with Tellus to support them in pursuing their mission to provid...